Molecular and functional heterogeneity of IL-10-producing CD4 + T cells

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Brockmann, Leonie ^a   Soukou, Shiwa ^a   Steglich, Babett ^a   Czarnewski, Paulo ^b   Zhao, Lilan ^a   Wende, Sandra ^a   Bedke, Tanja ^a   Ergen, Can ^a   Manthey, Carolin ^a   Agalioti, Theodora ^a   Geffken, Maria ^a   Seiz, Oliver ^a   Parigi, Sara M ^b   Sorini, Chiara ^b   Geginat, Jens ^c   Fujio, Keishi ^d   Jacobs, Thomas ^e   Roesch, Thomas ^a   Izbicki, Jacob R ^a   Lohse, Ansgar W ^a   Flavell, Richard A ^f   Krebs, Christian ^a   Gustafsson, Jan Ake ^b   Antonson, Per ^b   Roncarolo, Maria Grazia ^g   Villablanca, Eduardo J ^b   Gagliani, Nicola ^a,b   Huber, Samuel ^a   more..

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b KAROLINSKA INSTITUTE   (Sweden)

^c National Institute of Molecular Genetics Romeo ed Enrica Invernizzi INGM   (Italy)

^d UNIVERSITY OF TOKYO   (Japan)

^e BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTOME; IL10 PROTEIN, HUMAN; IL10 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HOMEOSTASIS; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; TRANSCRIPTION REGULATION; ANIMAL; C57BL MOUSE; HUMAN; IMMUNOLOGY; METABOLISM; SINGLE CELL ANALYSIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; MICE, INBRED C57BL; SINGLE-CELL ANALYSIS; TRANSCRIPTOME;

EID: 85058925987     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-07581-4     Document Type: Article

References (80)

1. Glocker, E. O. et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033–2045 (2009).
2. Kotlarz, D. et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology 143, 347–355 (2012).
3. Kucharzik, T., Stoll, R., Lugering, N. & Domschke, W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin. Exp. Immunol. 100, 452–456 (1995).
4. Gasche, C. et al. IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease. J. Clin. Immunol. 20, 362–370 (2000).
5. Melgar, S. et al. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis. Clin. Exp. Immunol. 134, 127–137 (2003).
6. Saito, T. et al. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers. Nat. Med. 22, 679–684 (2016).
7. Uhlig, H. H. et al. Characterization of Foxp3+CD4+CD25+and IL-10-secreting CD4+CD25+T cells during cure of colitis. J. Immunol. 177, 5852–5860 (2006).
8. Yu, Q. T. et al. Expression and functional characterization of FOXP3+CD4+regulatory T cells in ulcerative colitis. Inflamm. Bowel Dis. 13, 191–199 (2007).
9. Maul, J. et al. Peripheral and intestinal regulatory CD4+CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128, 1868–1878 (2005).
10. Roncarolo, M. G. et al. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev. 212, 28–50 (2006).
11. Gagliani, N. et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat. Med. 19, 739–746 (2013).
12. Facciotti, F. et al. IL-10-producing forkhead box protein 3-negative regulatory T cells inhibit B-cell responses and are involved in systemic lupus erythematosus. J. Allergy Clin. Immunol. 137, 318–321 (2016). e315.
13. Bacchetta, R. et al. Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-anergized donor T cells. Front. Immunol. 5, 16 (2014).
14. Sumitomo, S. et al. Identification of tonsillar CD4+CD25-LAG3+T cells as naturally occurring IL-10-producing regulatory T cells in human lymphoid tissue. J. Autoimmun. 76, 75–84 (2017).
15. Andreani, M. et al. Mixed chimerism evolution is associated with T regulatory type 1 (Tr1) cells in a beta-thalassemic patient after haploidentical haematopoietic stem cell transplantation. Chimerism 5, 75–79 (2014).
16. Amodio, G. et al. HLA-G expression levels influence the tolerogenic activity of human DC-10. Haematologica 100, 548–557 (2015).
17. Petrelli, A. et al. Generation of donor-specific T regulatory type 1 cells from patients on dialysis for cell therapy after kidney transplantation. Transplantation 99, 1582–1589 (2015).
18. Yao, Y. et al. Tr1 cells, but not Foxp3+regulatory T cells, suppress NLRP3 inflammasome activation via an IL-10-dependent mechanism. J. Immunol. 195, 488–497 (2015).
19. Mascanfroni, I. D. et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 21, 638–646 (2015).
20. Burton, B. R. et al. Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy. Nat. Commun. 5, 4741 (2014).
21. Pot, C. et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J. Immunol. 183, 797–801 (2009).
22. Iwasaki, Y. et al. Egr-2 transcription factor is required for Blimp-1-mediated IL-10 production in IL-27-stimulated CD4+T cells. Eur. J. Immunol. 43, 1063–1073 (2013).
23. Okamura, T. et al. CD4+CD25-LAG3+regulatory T cells controlled by the transcription factor Egr-2. Proc. Natl Acad. Sci. USA 106, 13974–13979 (2009).
24. Karwacz, K. et al. Critical role of IRF1 and BATF in forming chromatin landscape during type 1 regulatory cell differentiation. Nat. Immunol. 18, 412–421 (2017).
25. Zhang, P. et al. Eomesodermin promotes the development of type 1 regulatory T (TR1) cells. Sci. Immunol. 2, eaah7152 (2017).
26. Huang, W., Solouki, S., Koylass, N., Zheng, S. G. & August, A. ITK signalling via the Ras/IRF4 pathway regulates the development and function of Tr1 cells. Nat. Commun. 8, 15871 (2017).
27. Brockmann, L. et al. IL-10 receptor signaling is essential for TR1 cell function in vivo. J. Immunol. 198, 1130–1141 (2017).
28. Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015).
29. Kamanaka, M. et al. Memory/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 208, 1027–1040 (2011).
30. Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).
31. Syed Khaja, A. S., Toor, S. M., El Salhat, H., Ali, B. R. & Elkord, E. Intratumoral FoxP3+Helios+regulatory T cells upregulating immunosuppressive molecules are expanded in human colorectal cancer. Front. Immunol. 8, 619 (2017).
32. Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+T regulatory cells. J. Immunol. 184, 3433–3441 (2010).
33. Chinen, T. et al. An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322–1333 (2016).
34. Klocke, K., Holmdahl, R. & Wing, K. CTLA-4 expressed by FOXP3+regulatory T cells prevents inflammatory tissue attack and not T-cell priming in arthritis. Immunology 152, 125–137 (2017).
35. Barnes, M. J. et al. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria. Mucosal Immunol. 6, 324–334 (2013).
36. Apetoh, L. et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 11, 854–861 (2010).
37. Miyazaki, M. et al. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease. Nat. Immunol. 15, 767–776 (2014).
38. Shaw, L. A. et al. Id2 reinforces TH1 differentiation and inhibits E2A to repress TFH differentiation. Nat. Immunol. 17, 834–843 (2016).
39. Gandhi, R. et al. Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells. Nat. Immunol. 11, 846–853 (2010).
40. Grossman, W. J. et al. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 104, 2840–2848 (2004).
41. Ashton-Rickardt, P. G. An emerging role for Serine Protease Inhibitors in T lymphocyte immunity and beyond. Immunol. Lett. 152, 65–76 (2013).
42. Azzi, J. et al. Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells. J. Immunol. 191, 2319–2327 (2013).
43. Ge, G. et al. Induction of CD4+CD25+Foxp3+T regulatory cells by dendritic cells derived from ILT3 lentivirus-transduced human CD34+cells. Transpl. Immunol. 26, 19–26 (2012).
44. Brown, D. P. et al. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection. BMC Immunol. 10, 56 (2009).
45. Ulges, A. et al. Protein kinase CK2 enables regulatory T cells to suppress excessive TH2 responses in vivo. Nat. Immunol. 16, 267–275 (2015).
46. Zhao, Z. et al. IL-12R beta 2 promotes the development of CD4+CD25+regulatory T cells. J. Immunol. 181, 3870–3876 (2008).
47. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2, 933–944 (2002).
48. Mahmud, S. A. et al. Costimulation via the tumor-necrosis factor receptor superfamily couples TCR signal strength to the thymic differentiation of regulatory T cells. Nat. Immunol. 15, 473–481 (2014).
49. Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y. & Sakaguchi, S. Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135–142 (2002).
50. Satoguina, J. S. et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur. J. Immunol. 38, 3101–3113 (2008).
51. Amir el, A. D. et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31, 545–552 (2013).
52. Mackroth, M. S., Abel, A., Steeg, C., Schulze Zur Wiesch, J. & Jacobs, T. Acute malaria induces PD1+CTLA4+effector T cells with cell-extrinsic suppressor function. PLoS Pathog. 12, e1005909 (2016).
53. Sadasivam, S. & DeCaprio, J. A. The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat. Rev. Cancer 13, 585–595 (2013).
54. Dimova, D. K. & Dyson, N. J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810–2826 (2005).
55. Vincent-Fabert, C. et al. PLZF mutation alters mouse hematopoietic stem cell function and cell cycle progression. Blood 127, 1881–1885 (2016).
56. Kim, S. Y. et al. Liver X receptor and STAT1 cooperate downstream of Gas6/Mer to induce anti-inflammatory arginase 2 expression in macrophages. Sci. Rep. 6, 29673 (2016).
57. Zelcer, N. & Tontonoz, P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116, 607–614 (2006).
58. Ito, A. et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife 4, e08009 (2015).
59. Herold, M. et al. Liver X receptor activation promotes differentiation of regulatory T cells. PLoS ONE 12, e0184985 (2017).
60. Clemente-Casares, X. et al. Expanding antigen-specific regulatory networks to treat autoimmunity. Nature 530, 434–440 (2016).
61. Mfarrej, B. et al. Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression. J. Transl. Med. 15, 40 (2017).
62. Tousa, S. et al. Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses. Proc. Natl Acad. Sci. USA 114, E2891–E2900 (2017).
63. Koch, K. et al. Increased frequency of CD49b/LAG-3(+) type 1 regulatory T cells in HIV-infected individuals. AIDS Res. Hum. Retroviruses 31, 1238–1246 (2015).
64. Singha, S. et al. Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices. Nat. Nanotechnol. 12, 701–710 (2017).
65. Jakobsson, T. et al. The oxysterol receptor LXRbeta protects against DSS- and TNBS-induced colitis in mice. Mucosal Immunol. 7, 1416–1428 (2014).
66. Joseph, S. B. et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl Acad. Sci. USA 99, 7604–7609 (2002).
67. Schultz, J. R. et al. Role of LXRs in control of lipogenesis. Genes Dev. 14, 2831–2838 (2000).
68. Vigne, S. et al. IL-27-induced type 1 regulatory T-cells produce oxysterols that constrain IL-10 production. Front. Immunol. 8, 1184 (2017).
69. Huynh, J. P. et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection. J. Exp. Med. 215, 1823–1838 (2018).
70. Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s disease. Gastroenterology 143, 1207–1217 (2012). e1201-1202.
71. Marlow, G. J., van Gent, D. & Ferguson, L. R. Why interleukin-10 supplementation does not work in Crohn’s disease patients. World J. Gastroenterol. 19, 3931–3941 (2013).
72. Alberti, S. et al. Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice. J. Clin. Invest. 107, 565–573 (2001).
73. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15–21 (2013).
74. Ramskold, D., Wang, E. T., Burge, C. B. & Sandberg, R. An abundance of ubiquitously expressed genes revealed by tissue transcriptome sequence data. PLoS Comput. Biol. 5, e1000598 (2009).
75. Storvall, H., Ramskold, D. & Sandberg, R. Efficient and comprehensive representation of uniqueness for next-generation sequencing by minimum unique length analyses. PLoS One 8, e53822 (2013).
76. Love, M. I., Anders, S., Kim, V. & Huber, W. RNA-Seq workflow: gene-level exploratory analysis and differential expression. F1000Research 4, 1070 (2015).
77. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
78. Lun, A. T., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res. 5, 2122 (2016).
79. Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54–61 (2015).
80. Lun, A. T., Bach, K. & Marioni, J. C. Pooling across cells to normalize single-cell RNA sequencing data with many zero counts. Genome Biol. 17, 75 (2016).